|
TMEM194A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.9515946898282E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.23340000002248E-06 |
| Normal-vs-Stage2 |
6.458700E-03 |
| Normal-vs-Stage3 |
1.281090E-03 |
| Normal-vs-Stage4 |
3.540300E-02 |
| Stage1-vs-Stage2 |
7.025200E-01 |
| Stage1-vs-Stage3 |
5.761600E-01 |
| Stage1-vs-Stage4 |
1.318000E-01 |
| Stage2-vs-Stage3 |
9.202800E-01 |
| Stage2-vs-Stage4 |
2.903200E-01 |
| Stage3-vs-Stage4 |
2.856400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.88019608163381E-11 |
| Normal-vs-AfricanAmerican |
7.98570000000165E-05 |
| Normal-vs-Asian |
3.413200E-01 |
| Caucasian-vs-AfricanAmerican |
3.672200E-01 |
| Caucasian-vs-Asian |
6.506300E-02 |
| AfricanAmerican-vs-Asian |
4.055600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.12310050148778E-10 |
| Normal-vs-Female |
6.44120000004023E-07 |
| Male-vs-Female |
1.882000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.875000E-03 |
| Normal-vs-Extreme_Weight |
3.982000E-04 |
| Normal-vs-Obese |
7.73450000046694E-07 |
| Normal-vs-Extreme_Obese |
5.501600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.192600E-01 |
| Normal_Weight-vs-Obese |
8.625900E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.957600E-01 |
| Extreme_Weight-vs-Obese |
2.708300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.563400E-01 |
| Obese-vs-Extreme_Obese |
7.312400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.577700E-03 |
| Normal-vs-Age(41-60Yrs) |
8.78497274925394E-12 |
| Normal-vs-Age(61-80Yrs) |
2.12439999999203E-05 |
| Normal-vs-Age(81-100Yrs) |
3.182800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.579000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.584650E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.219900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.706400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.918100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.722000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.71790359715374E-11 |
| Normal-VS-Type2 PRCC |
1.379750E-02 |
| Normal-VS-KIRP CIMP |
2.386500E-02 |
| Normal-VS-Unclassified PRCC |
3.751300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.197500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.392020E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.423200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.184400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.469800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.098000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.663700E-03 |
| Normal-vs-N1 |
4.844500E-03 |
| Normal-vs-N2 |
1.235600E-01 |
| N0-vs-N1 |
2.700200E-02 |
| N0-vs-N2 |
1.815670E-02 |
| N1-vs-N2 |
9.401200E-01 |
|
|
